LONDON - Cambridge Cognition Holdings (LON:COGC) Plc (AIM: COG), a company specializing in the development and marketing of digital solutions for assessing brain health, has reported a share purchase by one of its directors. Nick Rodgers, serving as a Non-Executive Director, acquired 31,292 ordinary shares at an average price of 31.88 pence per share on Monday.
This transaction, conducted on the London Stock Exchange (LON:LSEG), increased Rodgers' total holding to 51,292 ordinary shares, which now accounts for approximately 0.12% of the company's issued share capital. The purchase is seen as a direct investment by a member of the company's board, indicating a personal stake in the business's success.
The shares, identified by the code GB00B8DV9647, were bought in two separate transactions, with 18,830 shares purchased at 31.8 pence each and 12,462 shares at 32.0 pence each.
The disclosure of this information is in line with regulatory requirements that mandate public notification of transactions by persons discharging managerial responsibilities. The company has provided the necessary details in accordance with the regulations.
Cambridge Cognition's notification of this share purchase comes amid its ongoing efforts to advance the field of digital health, particularly focusing on cognitive assessments. The company's position in the market is part of a larger industry trend towards leveraging technology in healthcare diagnostics and treatment.
The information presented in this article is based on a press release statement from Cambridge Cognition Holdings Plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.